Celularity, Inc. (CELU)
1.34
-0.07
(-4.96%)
USD |
NASDAQ |
Sep 14, 10:51
Celularity Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2025 | 4.524 |
| March 27, 2025 | 4.797 |
| March 26, 2025 | 5.128 |
| March 25, 2025 | 5.486 |
| March 24, 2025 | 4.771 |
| March 21, 2025 | 4.644 |
| March 20, 2025 | 4.414 |
| March 19, 2025 | 4.261 |
| March 18, 2025 | 3.929 |
| March 17, 2025 | 3.802 |
| March 14, 2025 | 3.955 |
| March 13, 2025 | 3.929 |
| March 12, 2025 | 4.006 |
| March 11, 2025 | 3.419 |
| March 10, 2025 | 3.342 |
| March 07, 2025 | 3.138 |
| March 06, 2025 | 3.317 |
| March 05, 2025 | 3.496 |
| March 04, 2025 | 2.756 |
| March 03, 2025 | 2.985 |
| February 28, 2025 | 2.960 |
| February 27, 2025 | 3.113 |
| February 26, 2025 | 3.496 |
| February 25, 2025 | 3.700 |
| February 24, 2025 | 4.082 |
| Date | Value |
|---|---|
| February 21, 2025 | 4.286 |
| February 20, 2025 | 4.593 |
| February 19, 2025 | 4.797 |
| February 18, 2025 | 4.924 |
| February 14, 2025 | 5.460 |
| February 13, 2025 | 5.230 |
| February 12, 2025 | 4.797 |
| February 11, 2025 | 5.026 |
| February 10, 2025 | 5.332 |
| February 07, 2025 | 5.511 |
| February 06, 2025 | 6.20 |
| February 05, 2025 | 6.761 |
| February 04, 2025 | 5.077 |
| February 03, 2025 | 5.154 |
| January 31, 2025 | 5.230 |
| January 30, 2025 | 5.639 |
| January 29, 2025 | 5.970 |
| January 28, 2025 | 6.302 |
| January 27, 2025 | 6.226 |
| January 24, 2025 | 6.379 |
| January 23, 2025 | 5.868 |
| January 22, 2025 | 5.919 |
| January 21, 2025 | 5.894 |
| January 17, 2025 | 5.868 |
| January 16, 2025 | 5.613 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tenax Therapeutics, Inc. | 0.5176 |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 8.416 |
| Century Therapeutics, Inc. | 1.515 |
| Absci Corp. | 5.632 |
Price to Book Value Related Metrics
| PS Ratio | 1.296 |
| PEG Ratio | -0.0106 |
| Price | 1.34 |
| Earnings Yield | -267.5% |
| Market Cap | 38.64M |
| PEGY Ratio | -0.0106 |